$55.81
2.975.62%
Last update: Oct 9, 4:00 PM
$52.95
0.110.21%
AtriCure Inc
ATRCNASDAQ
AtriCure (ATRC) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
AtriCure (ATRC) last issued guidance on July 23, 2026 for fiscal year 2026. The company guided earnings per share in the range of $0.24 - $0.32, compared to a consensus EPS estimate of $0.12. AtriCure also guided revenue in the range of $602M - $610M for the period.
Compared to prior guidance, AtriCure raised its EPS outlook from a previous range of $0 - $0.04. On the revenue side, the company maintained its revenue forecast from a prior range of $600M - $610M.
AtriCure has issued 29 guidance updates between November 1, 2022 and July 23, 2026. During this period, the company raised its outlook 14 times and lowered it 5 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.03 | $-0.06 | $-0.04 | $-0.11 |
| Actual | $0.18 | $0.00 | $0.06 | $-0.01 |
| Surprise | +500.0% | +100.0% | +250.0% | +90.9% |
| Revenue | ||||
| Estimate | $151.8M | $139.7M | $140.1M | $131.4M |
| Actual | $153.6M | $141.2M | $140.5M | $134.3M |
| Surprise | +1.20% | +1.13% | +0.31% | +2.21% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.01 | $0.09 | $-0.05 | $0.15 |
| Revenue | ||||
| Consensus | $151.2M | $160.1M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 23, 2026 | $0.18 | $0.03 | 500.0 % |
| Q1 | May 5, 2026 | $0 | $-0.06 | 100.0 % |
| Q4 | Feb 17, 2026 | $0.06 | $-0.04 | 250.0 % |
| Q3 | Oct 29, 2025 | $-0.01 | $-0.11 | 90.9 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 23, 2026 | $153.60M | $151.77M | 1.20 % |
| Q1 | May 5, 2026 | $141.25M | $139.67M | 1.13 % |
| Q4 | Feb 17, 2026 | $140.50M | $140.06M | 0.31 % |
| Q3 | Oct 29, 2025 | $134.27M | $131.36M | 2.21 % |
